Suppr超能文献

21-羟化酶缺乏症患者治疗前后的血清瘦素水平。

Serum leptin levels in patients with 21-hydroxylase deficiency before and after treatment.

作者信息

Poyrazoglu Sükran, Günöz Hülya, Darendeliler Feyza

机构信息

Department of Pediatrics, Istanbul Univeristy, Istanbul Faculty of Medicine, Istanbul, Turkey.

出版信息

Turk J Pediatr. 2003 Jan-Mar;45(1):33-8.

Abstract

Increase in serum androgen levels results in suppression of serum leptin levels. In this study, the changes in serum leptin concentrations of children with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) with respect to their hyperandrogenism were investigated. Eleven children with 21-OHD and 25 healthy control children were included in the study. Before initiation of hydrocortisone, serum leptin levels in children with CAH were lower (1.7 +/- 1.3 ng/ml) than in the control group (5.3 +/- 4.01 ng/ml) (p<0.001). After three months of treatment, serum leptin levels increased to the normal range (7.1 +/- 2.9 ng/ml). Prior to and on hydrocortisone treatment in CAH, serum leptin levels were positively correlated with cortisol (r:0.78, p:0.004 and r:0.80, p:0.003) but negatively correlated with testosterone (r:-0.62, p:0.04 and r:-0.65, p:0.002). These results suggest that serum leptin measurements may be used as an additional parameter in the follow-up of children with CAH to evaluate the efficacy of hydrocortisone treatment with respect to androgenemia.

摘要

血清雄激素水平升高会导致血清瘦素水平受到抑制。在本研究中,对因21-羟化酶缺乏(21-OHD)所致先天性肾上腺皮质增生症(CAH)患儿血清瘦素浓度随其高雄激素血症的变化情况进行了研究。该研究纳入了11名21-OHD患儿和25名健康对照儿童。在开始氢化可的松治疗前,CAH患儿的血清瘦素水平(1.7±1.3 ng/ml)低于对照组(5.3±4.01 ng/ml)(p<0.001)。治疗三个月后,血清瘦素水平升至正常范围(7.1±2.9 ng/ml)。在CAH患儿接受氢化可的松治疗前及治疗期间,血清瘦素水平与皮质醇呈正相关(r分别为0.78,p为0.004;r为0.80,p为0.003),但与睾酮呈负相关(r分别为-0.62,p为0.04;r为-0.65,p为0.002)。这些结果表明,血清瘦素检测可作为CAH患儿随访中的一项额外参数,以评估氢化可的松治疗在雄激素血症方面的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验